Approximately 27,010 Shares Of Asensus Surgical Inc. (ASXC) Were Sold By This Insider.

0
6
KOSK
KOSK

Asensus Surgical Inc. (AMEX:ASXC) traded with a subtraction of -$0.04 to $0.47 on Thursday, a downside of -8.20 percent. An average of 690,528 shares of common stock have been traded in the last five days. There was a fall of -$0.0815 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 957,407 shares traded, while the 50-day average volume stands at 1,391,711.

ASXC stock has decreased by -9.80% in the last month. The company shares reached their 1-month lowest point of $0.4626 on 09/22/22. With the stock rallying to its 52-week high on 01/04/22, shares of the company touched a low of $0.35 and a high of $2.31 in 52 weeks. It has reached a new high 2 times so far this year and lost -53.88% or -$0.6449 in price. In spite of this, the price is down -79.66% from the 52-week high.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .

Sponsored


Insider Transactions

101 days have passed since Asensus Surgical Inc. (ASXC) last reported insider trading activity. Starling William N JR, who is Director, most recently acquired $27,010 shares at $0.40 per share on Jun 13.

Valuation Metrics

Asensus Surgical Inc. (ASXC) stock’s beta is 1.45. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 16.28, the price-to-book (PB) ratio at 0.91.

Financial Health

The quick ratio of Asensus Surgical Inc. for the three months ended March 30 was 10.30, and the current ratio was 11.20, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.00 for the quarter ending March 30. Its gross profit as reported stood at -$2.86 million compared to revenue of $8.23 million.

For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Asensus Surgical Inc.’s return on assets was -40.40%.

Earnings Surprise

For the three-month period that ended March 30, Asensus Surgical Inc. had $83.36 million in cash. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of -$19.62 million in the quarter, while revenues of -$19.13 million were grew 32.87%. The analyst consensus anticipated Asensus Surgical Inc.’s latest quarter earnings to come in at -$0.08 per share, but it turned out to be -$0.08, a 0.00% surprise. For the quarter, EBITDA amounted to -$15.95 million. Shareholders own equity worth $236.72 million.

Technical Picture

From a technical analysis perspective, let’s take a brief look at Asensus Surgical Inc. (ASXC) price momentum. RSI 9-day as of the close on 21 September was 30.33%, suggesting the stock is Neutral, with historical volatility in this time frame at 64.22%.

As of today, ASXC’s price is $0.5195 -14.91% or -$0.0815 from its 5-day moving average. ASXC is currently trading -18.12% lower than its 20-day SMA and +2.60% higher than its 100-day SMA. However, the stock’s current price level is +0.02% above the SMA50 and -60.25% below the SMA200.

The stochastic %K and %D were 20.34% and 31.88%, respectively, and the average true range (ATR) was 0.0480. With the 14-day stochastic at 1.82% and the average true range at 0.0497, the RSI (14) stands at 36.86%. The stock has reached -0.0355 on the 9-day MACD Oscillator while the 14-day reading was at -0.0373.

Analyst Ratings

Cantor Fitzgerald launched coverage on Asensus Surgical Inc. (AMEX: ASXC) in its analyst report released on September 08, 2022. The firm assigned the stock an Overweight rating. The consensus rating for Asensus Surgical Inc. (ASXC) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell ASXC, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 2 others rate it as a “buy”.

What is ASXC’s price target for the next 12 months?

Analysts predict a range of price targets between $1.50 and $3.00, with a median target of $2.25. Taking a look at these predictions, the average price target given by analysts for Asensus Surgical Inc. (ASXC) stock is $2.25.

LEAVE A REPLY

Please enter your comment!
Please enter your name here